Menopause: identification and management

Supporting evidence

• Other supporting evidence

• Supplement 1: Methods (PDF 276 KB)

  Published:

  07 November 2024

• Supplement 2: Health economics (PDF 321 KB)

  Published:

  07 November 2024

• Supplement 3: Acknowledgements (PDF 120 KB)

  Published:

  07 November 2024

• Supplement 4: [B1] TSU NMA software code (PDF 144 KB)

  Published:

  07 November 2024

• Supplement 5: [B1] TSU NMA software code inconsistency model (PDF 139 KB)

  Published:

  07 November 2024

• Supplement 6: [B1] TSU NMA model fit statistics (PDF 156 KB)

  Published:

  07 November 2024

• Supplement 7: [B1] TSU NMA sensitivity analyses forest plots (PDF 555 KB)

  Published:

  07 November 2024

• Supplement 8: [B1] TSU NMA data extraction (Excel 160 KB)

  Published:

  07 November 2024

• Supplement 9: [B1] data discae_short_biasadjust (Excel 81 KB)

  Published:

  07 November 2024

• Supplement 10: [B1] data discae_short_fclass (Excel 876 KB)

  Published:

  07 November 2024

• Supplement 11: [B1] data discomfort_biasadjust (Excel 70 KB)

  Published:

  07 November 2024

• Supplement 12: [B1] data discomfort_fclass (Excel 760 KB)

  Published:

  07 November 2024

• Supplement 13: [B1] data dryness_biasadjust (Excel 92 KB)

  Published:

  07 November 2024

• Supplement 14: [B1] data dryness_fclass (Excel 931 KB)

  Published:

  07 November 2024

• Supplement 15: [B1] data dyspar_biasadjust (Excel 64 KB)

  Published:

  07 November 2024

• Supplement 16: [B1] data dyspar_fclass (Excel 671 KB)

  Published:

  07 November 2024

• Supplement 17: [C] outcome data - RCTs (Excel 57 KB)

  Published:

  07 November 2024

• Supplement 18: [C] outcome data: observational studies (Excel 64 KB)

  Published:

  07 November 2024

• Supplement 19: Absolute calculations (Excel 58 KB)

  Published:

  07 November 2024

• Economic model - Cost utility analysis: Interventions for bothersome genitourinary symptoms associated with the menopause (Excel 44.77 MB)

  Published:

  07 November 2024

• Evidence review

• Evidence reviews – November 2024

• A: Cognitive behavioural therapy (PDF 3.41 MB)

  Published:

  07 November 2024

• B1: Managing genitourinary symptoms (network meta-analyses) (PDF 3.87 MB)

  Published:

  07 November 2024

• B2: Managing genitourinary symptoms (breast cancer recurrence) (PDF 1 MB)

  Published:

  07 November 2024

• C: Cardiovascular disease and stroke (PDF 6.37 MB)

  Published:

  07 November 2024

• D: Breast cancer (PDF 3.35 MB)

  Published:

  07 November 2024

• E: Endometrial cancer (PDF 3 MB)

  Published:

  07 November 2024

• F: Ovarian cancer (PDF 2.66 MB)

  Published:

  07 November 2024

• G: Dementia (PDF 1.65 MB)

  Published:

  07 November 2024

• H: All-cause mortality (PDF 1.6 MB)

  Published:

  07 November 2024

• I: Early menopause (PDF 1.11 MB)

  Published:

  07 November 2024

• Surveillance report

• 2024 exceptional surveillance of menopause: diagnosis and management (NICE guideline NG23)

• 2021 exceptional surveillance of menopause: diagnosis and management (NICE guideline NG23)

• 2019 surveillance of menopause: diagnosis and management (NICE guideline NG23)

• Appendix A: Summary of evidence from surveillance (PDF 1.72 MB)

  Published:

  05 December 2019

• Appendix B: Stakeholder consultation comments table (PDF 999 KB)

  Published:

  05 December 2019

• Full guidance

• Full guideline (PDF 3.28 MB)

  Published:

  12 November 2015

• Appendices A-G (PDF 6.49 MB)

  Published:

  12 November 2015

• Appendix H (PDF 8.68 MB)

  Published:

  12 November 2015

• Appendices I-K (PDF 7.04 MB)

  Published:

  12 November 2015

• Appendix L-M (PDF 2.82 MB)

  Published:

  12 November 2015